Mannkind (MNKD) Capital Expenditures (2010 - 2026)
Mannkind (MNKD) reported Capital Expenditures of $267000.0 for Q1 2026, down 19.09% year-over-year from $330000.0 in Q1 2025, and up 229.61% on a QoQ basis from -$206000.0 in Q4 2025.
Mannkind (MNKD) has 15 years of Capital Expenditures data on file, last reported at $267000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 19.09% year-over-year to $267000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $556000.0 (down 93.35% YoY) and the FY2025 annual result came in at $619000.0, down 93.61% from the prior year.
- Capital Expenditures climbed to $267000.0 in Q1 2026 per MNKD's latest filing, from -$206000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $22.7 million in Q2 2023 and bottomed at -$22.7 million in Q3 2023.
- The 5-year median for Capital Expenditures is $330000.0 (2025), against an average of $1.2 million.
- The widest annual swing landed in 2023, when Capital Expenditures plunged 2775.79%; it then jumped 1127.16% in 2024.
- Tracing MNKD's Capital Expenditures over 5 years: stood at $6.2 million in 2022, then tumbled by 112.98% to -$799000.0 in 2023, then jumped by 1127.16% to $8.2 million in 2024, then slumped by 102.51% to -$206000.0 in 2025, then surged by 229.61% to $267000.0 in 2026.
- Per Business Quant, the three latest MNKD Capital Expenditures figures stand at $267000.0 (Q1 2026), -$206000.0 (Q4 2025), and -$622000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 267,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 267,000.00 |
| Mar 31, 2026 | 267,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Sep 30, 2025 | -622,000.00 |
| Sep 30, 2025 | -622,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 330,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 8.21 Mn |
| Dec 31, 2024 | 8.21 Mn |
| Sep 30, 2024 | -3.89 Mn |
| Sep 30, 2024 | -3.89 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | -799,000.00 |
| Dec 31, 2023 | -799,000.00 |
| Sep 30, 2023 | -22.69 Mn |
| Sep 30, 2023 | -22.69 Mn |
| Jun 30, 2023 | 22.74 Mn |
| Jun 30, 2023 | 22.74 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 6.16 Mn |
| Dec 31, 2022 | 6.16 Mn |
| Sep 30, 2022 | -789,000.00 |
| Sep 30, 2022 | -789,000.00 |
| Jun 30, 2022 | -2.83 Mn |
| Jun 30, 2022 | -2.83 Mn |
| Mar 31, 2022 | 5.06 Mn |
| Mar 31, 2022 | 5.06 Mn |
| Dec 31, 2021 | -5.01 Mn |
| Dec 31, 2021 | -5.01 Mn |
| Sep 30, 2021 | 5.09 Mn |
| Sep 30, 2021 | 5.09 Mn |
| Jun 30, 2021 | 207,000.00 |
| Jun 30, 2021 | 207,000.00 |
| Mar 31, 2021 | 976,000.00 |
| Mar 31, 2021 | 976,000.00 |
| Dec 31, 2020 | 497,000.00 |
| Dec 31, 2020 | 497,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 268,000.00 |
| Jun 30, 2020 | 268,000.00 |
| Mar 31, 2020 | 32,000.00 |
| Mar 31, 2020 | 32,000.00 |
| Dec 31, 2019 | 2.36 Mn |
| Dec 31, 2019 | 2.36 Mn |
| Sep 30, 2019 | -587,000.00 |
| Sep 30, 2019 | -587,000.00 |
| Jun 30, 2019 | 521,000.00 |
| Jun 30, 2019 | 521,000.00 |
| Mar 31, 2019 | 269,000.00 |
| Mar 31, 2019 | 269,000.00 |
| Mar 31, 2016 | 1.14 Mn |
| Mar 31, 2016 | 1.14 Mn |
| Dec 31, 2015 | 316,000.00 |
| Dec 31, 2015 | 316,000.00 |
| Sep 30, 2015 | 1.23 Mn |
| Sep 30, 2015 | 1.23 Mn |
| Jun 30, 2015 | 4.53 Mn |
| Jun 30, 2015 | 4.53 Mn |
| Mar 31, 2015 | 4.20 Mn |
| Mar 31, 2015 | 4.20 Mn |
| Dec 31, 2014 | 4.96 Mn |
| Dec 31, 2014 | 4.96 Mn |
| Sep 30, 2014 | 9.47 Mn |
| Sep 30, 2014 | 9.47 Mn |
| Jun 30, 2014 | 8.26 Mn |
| Jun 30, 2014 | 8.26 Mn |
| Mar 31, 2014 | 1.41 Mn |
| Mar 31, 2014 | 1.41 Mn |
| Dec 31, 2013 | 6.17 Mn |
| Dec 31, 2013 | 6.17 Mn |
| Sep 30, 2013 | 230,000.00 |
| Sep 30, 2013 | 230,000.00 |
| Jun 30, 2013 | 132,000.00 |
| Jun 30, 2013 | 132,000.00 |
| Mar 31, 2013 | 1.46 Mn |
| Mar 31, 2013 | 1.46 Mn |
| Dec 31, 2012 | 65,000.00 |
| Dec 31, 2012 | 65,000.00 |
| Sep 30, 2012 | 124,000.00 |
| Sep 30, 2012 | 124,000.00 |
| Jun 30, 2012 | 125,000.00 |
| Jun 30, 2012 | 125,000.00 |
| Mar 31, 2012 | 323,000.00 |
| Mar 31, 2012 | 323,000.00 |
| Dec 31, 2011 | 155,000.00 |
| Dec 31, 2011 | 155,000.00 |
| Sep 30, 2011 | 594,000.00 |
| Sep 30, 2011 | 594,000.00 |
| Jun 30, 2011 | 4.12 Mn |
| Jun 30, 2011 | 4.12 Mn |
| Mar 31, 2011 | 1.99 Mn |
| Mar 31, 2011 | 1.99 Mn |
| Dec 31, 2010 | 3.94 Mn |
| Dec 31, 2010 | 3.94 Mn |
| Sep 30, 2010 | 1.56 Mn |
| Sep 30, 2010 | 1.56 Mn |